In April 2026, the FDA removed BPC-157 from its Category 2 list (substances with safety concerns that were previously restricted from compounding)
For a full breakdown of delivery forms, see Best Forms of BPC157: Injectable vs Oral vs Capsules Explained What to Stack with BPC-157 for Faster Recovery (Expanded) TB500 Why it pairs well: TB500 (Thymosin Beta-4) works systemically to improve cellular repair, reduce inflammation, and promote the migration of immune cells and actin-binding proteins to damaged areas
Protocol integration: Continue scheduled anti-VEGF injections (typically monthly or every 2 months)
580 FlugeBrulandORisaKStorsteinAKristoffersenEKSapkotaDet al
Neuroprotective Effects How it works: BPC-157 has been shown to protect neurons from toxins and injury, potentially reducing damage from traumatic brain injury
Furthermore, the agency said this was concerning, as the company has a history of obtaining unapproved products from foreign, unverified sources